June 19, 2024
by Andrii Buvailo
Biopharma insight
Foundation models represent a new paradigm in artificial intelligence (AI), revolutionizing how machine learning models are developed and deployed. As …
Sept. 11, 2024
by Andrii Buvailo, PhD
Biopharma insight
Roche has announced an expansion of its Digital Pathology Open Environment, integrating over 20 artificial intelligence (AI) algorithms from eight …
Sept. 11, 2024
by Roman Kasianov
News
This week, Creation Healthcare launched a new platform that's set to change how the pharmaceutical industry finds and connects with …
Sept. 11, 2024
by BiopharmaTrend
News
Cellino Biotech, Inc. has been awarded up to $25 million by the Advanced Research Projects Agency for Health (ARPA-H), part …
Sept. 10, 2024
by Roman Kasianov
News
Scientist.com has announced a partnership with Evotec SE, aimed at integrating Evotec’s advanced drug discovery and development services into Scientist.com’s …
Sept. 10, 2024
by Roman Kasianov
News
Relay Therapeutics has reported encouraging results from a small clinical trial of its experimental breast cancer drug, RLY-2608, which demonstrated …
Sept. 10, 2024
by Roman Kasianov
News
BIOCAPTIVA, a biotech company based in Edinburgh, has been granted its first US patent for a liquid biopsy technology designed …
Sept. 9, 2024
by Roman Kasianov
News
MGI Tech Co., Ltd., a global developer of life science technologies, has launched two new nanopore sequencing products, CycloneSEQ-WT02 and …
Sept. 9, 2024
by Roman Kasianov
News
Superluminal Medicines, Inc. has raised $120 million in a Series A funding round led by RA Capital Management, with participation …
Sept. 6, 2024
by Andrii Buvailo, PhD
Interview
As the demand for decentralized and hybrid clinical trials rises, Medable Inc. is positioning itself at the forefront of this …
Sept. 6, 2024
by Roman Kasianov
News
Eli Lilly has announced a partnership with Genetic Leap, a biotech company specializing in RNA-targeted drug discovery using AI models. …
Sept. 5, 2024
by Roman Kasianov
News
Neuralink recently captured the public's attention with the implantation of its brain chip in a second patient, allowing the person …